A 79-year-old man was admitted with asymptomatic elevation of liver enzymes and tumor markers. Abdominal contrast-enhanced computed tomography demonstrated swelling of the pancreatic head, and additional blood test showed raised IgG4 levels. Histological examination by endoscopic ultrasonography (EUS)-guided fine needle aspiration for pancreatic head mass revealed storiform fibrosis and IgG4-positive plasma cell infiltration. We diagnosed this case as type 1 autoimmune pancreatitis (AIP). In addition, there was a cystic lesion in the pancreatic body apart from the pancreatic head mass. A mural nodule in the multilocular cyst was detected by EUS, and there was positive uptake of fluorodeoxyglucose in positron emission tomography/magnetic resonance imaging. The preoperative diagnosis of this cystic lesion was intraductal papillary mucinous carcinoma, and distal pancreatomy was performed. Histopathological findings showed various sizes of retention cysts caused by IgG4-positive plasma cell Case Ezaki et al.: Type 1 Autoimmune Pancreatitis with Imaging Appearance Similar to That of Malignant Cystic Tumor 266
Introduction
Autoimmune pancreatitis (AIP) is chronic inflammatory pancreatitis associated with autoimmune manifestation. It is known that AIP rarely causes cystic lesions in the pancreas. Most of these cystic lesions have been reported to be pseudocysts or retention cysts caused by pancreatic duct stenosis with severe lymphoplasmacytic infiltration in the periductal area [1, 2] . However, it has also been reported that neoplastic cystic lesions sometimes coexist with AIP, which are intraductal papillary mucinous neoplasm or mucinous neoplasm [3, 4] . They often showed images similar to those of nonneoplastic cysts. Therefore, in most cases, it is difficult to distinguish neoplastic from nonneoplastic cysts. Herein, we describe an AIP case with mimicking neoplastic cyst and compare pathological and preoperative images.
Case Report
A 79-year-old male with a previous history of cholecystectomy and endoscopic choledocholithotomy was admitted with asymptomatic elevation of liver enzymes and tumor markers. Initial laboratory values showed total bilirubin at 1.1 mg/dL (normal 0.4-1.5), alkaline phosphatase at 1,544 U/L (normal 106-322), gamma-glutamyltranspeptidase at 1,031 U/L (normal 13-64), aspartate aminotransferase at 82 U/L (normal 13-30), alanine aminotransferase at 107 U/L (normal 10-42), carcinoembryonic antigen at 5.8 ng/mL (normal <5), carbohydrate-associated antigen 19-9 at 142 U/mL (normal <37), s-pancreas-1 antigen at 302 U/mL (normal <30), and pancreatic cancer-associated antigen at 61 U/mL (normal <150). Abdominal contrast-enhanced computed tomography demonstrated swelling of the pancreatic head and mild dilation of the intrahepatic and extrahepatic bile duct ( Fig. 1a, b ), and an additional blood test showed high IgG4 levels (774 mg/dL; normal 5-117). Endoscopic retrograde cholangiopancreatography revealed segmental narrowing of the main pancreatic duct in the pancreatic head without distal main pancreatic duct dilation and stenosis of the lower bile duct. Intraductal ultrasonography showed bile duct wall thickening with bile duct stricture. Bile duct biopsy did not show neoplastic change. Furthermore, histological examination by endoscopic ultrasonography (EUS)-guided fine needle biopsy for the pancreatic head mass revealed storiform fibrosis and IgG4-positive plasma cell infiltration. We diagnosed this case as type 1 AIP and IgG4-related sclerosing cholangitis.
In addition, there was a multilocular cystic lesion (maximum diameter 15 mm) in the pancreatic body apart from the pancreatic head swelling ( Fig. 1a ). Endoscopic retrograde cholangiopancreatography showed that the cyst communicated with the main pancreatic duct. Additionally, a mural nodule (maximum diameter 5 mm) was detected by EUS in the cyst (Fig. 1c , left panel), and that was enhanced by contrast-enhanced EUS (Fig. 1c , right panel). That lesion also showed positive uptake of fluorodeoxyglucose (FDG) in positron emission tomography/magnetic resonance imaging with a maximum standardized uptake value of 4.16 ( Fig. 1b ). Considering these results, our preoperative diagnosis of this cystic lesion was intraductal papillary mucinous carcinoma, and distal pancreatomy was performed.
Histopathological findings showed various sizes of retention cysts, which were lined by nonneoplastic pancreatic epithelium ( Fig. 2a ). These cysts were the dilated pancreatic branch ducts with diffuse infiltration of IgG4-positive plasma cells. The mural nodule was a fibrotic mass with severe infiltration of IgG4-positive cells (>100 IgG4-positive plasma cells per highpower field, IgG4+/IgG+ plasma cell ratio 65.6%; Fig. 2b ). Neoplastic change was not seen in the main and branch pancreatic ducts. The adjacent pancreatic parenchyma appeared to be atrophic with only mild inflammation, but foci of storiform fibrosis and obliterative phlebitis were observed, leading to the diagnosis of partly regressed AIP with residual periductal inflammation.
Discussion and Conclusion
AIP is a rare chronic inflammatory pancreatitis associated with autoimmune manifestation, which was first described by Sarles et al. [5] as hypergammaglobulinemia-associated chronic pancreatitis in 1961 and first named by Yoshida et al. [6] as AIP in 1995. Furthermore, Hamano et al. [7] firstly reported that serum IgG4 levels are significantly and specifically high in AIP patients. In 2011, the International Consensus Diagnostic Criteria proposed two types of AIP. Type 1 AIP is associated with histological feature called lymphoplasmacytic sclerosing pancreatitis with elevated serum IgG4, type 2 is characterized by idiopathic duct-centric pancreatitis with granulocytic epithelial lesion and serum IgG4 negativity [8] . In this case, pathological findings of lymphoplasmacytic sclerosing pancreatitis and serum IgG4 elevation were found, and that led to the diagnosed of type 1 AIP.
There have been only few reports of pancreatic cystic lesions associated with AIP. Most of these cystic lesions were reported to be located at the pancreatic body to tail, and they were pseudocysts or retention cysts caused by pancreatic duct stenosis with severe lymphoplasmacytic infiltration in the periductal area [1, 2] . It was also reported that neoplastic cystic lesions sometimes coexist with AIP, which are intraductal papillary mucinous neoplasm or mucinous neoplasm [3, 4] . They often showed images similar to those of nonneoplastic cysts. Therefore, in most cases, it is difficult to distinguish neoplastic from nonneoplastic cysts. In our case, it was hard to diagnose this lesion as nonneoplastic cyst even in retrospect.
In the present case, pathological examination revealed that the cystic lesion of the pancreatic body was a retention cyst lined by normal pancreatic epithelium without neoplastic changes. Although microscopic findings consistent with type 1 AIP (e.g., IgG4-positive cell infiltration, storiform fibrosis, and obliterative phlebitis) were observed, the degree of inflammation was markedly lower than that expected in untreated AIP. As shown in Figure 2 , EUS findings correlated well with the microscopic appearance. Intense lymphoplasmacytic infiltration was mainly noted in the subepithelial layer of the dilated duct, the histological finding likely corresponding to the FDG-positive mural nodule. Although type 1 AIP is typically a lobule-centric inflammatory process, parenchymal inflammation had already regressed at the initial presentation in the present case, which is probably the reason why imaging features were atypical for type 1 AIP.
It has been reported that AIP shows prompt response to corticosteroid treatment, usually within 1-4 weeks [9, 10] . In previous reports, most cases with cystic lesions associated with AIP also showed rapid response to corticosteroid treatment [1] . Especially, in case of cysts with a diameter <55 mm, 100% of patients improved with corticosteroid treatment within 4 weeks [2] . Corticosteroids may release the stasis of the pancreatic juice caused by pancreatic ductal stenosis due to the lymphoplasmacytic infiltration [1, 2] . Cystic lesions associated with AIP could be treated by corticosteroid therapy rather than interventional treatment as a firstline treatment.
A correct preoperative diagnosis is important to avoid unnecessary surgery. In our case, the cystic lesion looked like intraductal papillary mucinous carcinoma because of the enhanced mural nodule in contrast-enhanced EUS with instinct FDG uptake in positron emission tomography/magnetic resonance imaging. For suspected malignant tumor, there is still hesitation to use corticosteroids for differential diagnosis. In differentiating focal-type AIP from pancreatic cancer, some reports showed that steroid trial of only 2 weeks was effective [11, 12] . Therefore, even in our case, short-term steroid trial might be a potential treatment for differential diagnosis. However, it remains inconclusive to use corticosteroids for cystic lesions with malignant features in patients with AIP.
Statement of Ethics
The patient gave his informed consent before publication.
Disclosure Statement
The authors have no conflict of interest. 
